Propranolol, is a beta-blocker that inhibits the action of stress hormones. It was developed for high blood pressure and heart arrhythmias, has been around for a long time, and is already used as ...

A study has found that there are similar safety profiles for -blockers and verapamil in patients with low-risk hypertrophic ...

A well-studied, widely used class of drugs for heart health may have benefits for Huntington’s disease. A new paper ...

Ms Mettam is the only political leader in Australia with a policy to ban the use of puberty blockers, cross-sex hormone treatments, and surgical interventions for the gender transition of children ...

The United Kingdom indefinitely extended a ban on puberty blockers for people younger than 18, barring medication prescriptions used to treat gender dysphoria, the government announced this week.

Long-term treatment with beta-blockers may not lower the risk of death or myocardial infarction (MI) in patients with MI, a preserved left ventricular ejection fraction (LVEF) of ≥50% and coronary ...

Interruption of beta-blocker treatment in patients with a history of myocardial infarction (MI) did not reduce risk of cardiovascular events or death, nor did it appear to improve quality of life ...

Dec. 11 (UPI) --Britain announced Wednesday that a temporary ban barring the use of puberty blocker medication by minors is to become indefinite, stoking anger and criticism from LGBTQ advocates.

The ban on giving puberty blockers to under-18s questioning their gender identify is to be made permanent, Health Secretary Wes Streeting has announced. Streeting told MPs he was making the ...

LONDON — (AP) — The British government on Wednesday indefinitely banned puberty blockers for children with gender dysphoria after independent experts found there was an unacceptable safety ...

Copyright 2024 The Associated Press. All Rights Reserved. Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] LONDON (AP) — The British government ...

The UK government will indefinitely ban prescriptions of puberty blockers for under-18s in cases of gender dysphoria, making it the latest country in Europe to enact restrictions on gender-affirming ...